ArticleCanadian Urological Association journal = Journal de l'Association des urologues du Canada2020

Real-world evidence in patient-reported outcomes (PROs) of metastatic castrate-resistant prostate cancer (mCRPC) patients treated with abiraterone acetate + prednisone (AA+P) across Canada: Final results of COSMiC.

Geoffrey Gotto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.